BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9627081)

  • 1. Enhanced hemodynamic response to [D-ALA2,D-MET5]-methionine enkephalin (DAME) in streptozotocin-induced diabetic rats is reversed by insulin replacement.
    Severson K; Tackett RL
    Life Sci; 1998; 62(24):2219-29. PubMed ID: 9627081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of 17-alpha-estradiol, a possible endogenous opiate antagonist, on D-ala2-met5-enkephalinamide-induced blood pressure responses in conscious, unrestrained rats.
    Chandra A; Dixon WR
    NIDA Res Monogr; 1986; 75():339-42. PubMed ID: 3123948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The opioid peptide analog D-Ala2-Met-enkephalinamide decreases bile flow by a central mechanism.
    Bergasa NV; Zhou J; Ravi J; Shi Q
    Peptides; 1999; 20(8):979-86. PubMed ID: 10503777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of opioid receptor activation on cardiovascular responses and extracellular monoamines within the rostral ventrolateral medulla during static contraction of skeletal muscle.
    Nauli SM; Maher TJ; Pearce WJ; Ally A
    Neurosci Res; 2001 Dec; 41(4):373-83. PubMed ID: 11755224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enkephalins induce a centrally mediated rise in blood pressure in rats.
    Petty MA; de Jong W
    Brain Res; 1983 Feb; 260(2):322-5. PubMed ID: 6299461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enkephalin lowers vascular resistance in dog hindlimb via a peripheral nonlimb site.
    Caffrey JL; Gu H; Barron BA; Gaugl JF
    Am J Physiol; 1991 Feb; 260(2 Pt 2):H386-92. PubMed ID: 1847597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure responses of conscious rats to intravenous administration of enkephalin derivatives (D-ala2 methionine and leucine enkephalinamide, and methionine and leucine enkephalinamide.
    Thornhill JA; Saunders WS
    Peptides; 1985; 6(6):1253-6. PubMed ID: 3834418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central cardiovascular actions of D-Ala2-Met5-enkephalinamide in the rat: effects of naloxone and nucleus reticularis gigantocellularis lesion.
    Wong TM; Chan SH; Tse SY
    Neurosci Lett; 1984 May; 46(3):249-54. PubMed ID: 6377125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-week administration of nimesulide, a cyclooxygenase-2 inhibitor, improves endothelial dysfunction in the hindlimb vasculature of streptozotocin-induced diabetic rats.
    Abdelrahman AM; Al Suleimani YM
    Arch Pharm Res; 2008 Dec; 31(12):1584-9. PubMed ID: 19099228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of (D-Ala2)-Met-enkephalin on the contraction of nictitating membrane in cats.
    Yen MH; Ku PY; Lee HK
    Eur J Pharmacol; 1980 May; 63(2-3):213-6. PubMed ID: 7379855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of [D-Ala2]-methionine-enkephalin on blood pressure, heart rate, and baroreceptor reflex sensitivity in conscious cats.
    Yukimura T; Stock G; Stumpf H; Unger T; Ganten D
    Hypertension; 1981; 3(5):528-33. PubMed ID: 7298107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intracerebroventricular D-ALA2 methionine enkephalinamide and naloxone on cardiovascular parameters in the cat.
    Lathers CM; Tumer N; Kraras CM
    Life Sci; 1988; 43(26):2287-98. PubMed ID: 3210904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
    Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of [Met5]enkephalin on regional blood flow and vascular resistance in rabbits.
    Eulie PJ; Rhee HM; Laughlin MH
    Eur J Pharmacol; 1987 May; 137(1):25-31. PubMed ID: 3609133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute vasoconstriction-induced insulin resistance in rat muscle in vivo.
    Rattigan S; Clark MG; Barrett EJ
    Diabetes; 1999 Mar; 48(3):564-9. PubMed ID: 10078557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rostral ventrolateral medulla opioid receptor activation modulates glutamate release and attenuates the exercise pressor reflex.
    Ishide T; Mancini M; Maher TJ; Chayaikul P; Ally A
    Brain Res; 2000 May; 865(2):177-85. PubMed ID: 10821919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure and splanchnic nerve activity are reduced by a vagally mediated opioid action.
    Willette RN; Krieger AJ; Sapru HN
    J Cardiovasc Pharmacol; 1982; 4(6):1006-11. PubMed ID: 6185764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is compensatory vasoconstrictor tone in the hindquarter vascular region induced by hemorrhage in conscious spontaneously hypertensive rats?
    Teranishi Y; Iida N; Ishioka N; Sugino H; Amano T
    Jpn J Pharmacol; 2001 Jan; 85(1):109-13. PubMed ID: 11243564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertensive response following stimulation of opiate receptors in the caudal ventrolateral medulla.
    Willette RN; Punnen S; Krieger AJ; Sapru HN
    Neuropharmacology; 1984 Apr; 23(4):401-6. PubMed ID: 6145114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomic effects of central injections of D-Ala2-Met-enkephalinamide (DAME) in the conscious monkey.
    Owen MD; Gisolfi CV; Reynolds DG; Gurll NJ
    Peptides; 1984; 5(4):737-42. PubMed ID: 6494024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.